Meta-Analysis of Randomized Controlled Trials Evaluating the Effect of Dual Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Receptor Agonists on Blood Pressure Levels in Patients With Type 2 Diabetes Mellitus

Feb 19, 2022 by in CARDIOLOGY Comments Off on Meta-Analysis of Randomized Controlled Trials Evaluating the Effect of Dual Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Receptor Agonists on Blood Pressure Levels in Patients With Type 2 Diabetes Mellitus

Hypertension and type 2 diabetes mellitus (T2DM) are common co-morbidities, with hypertension being twice as frequent in patients with T2DM as in those without. , Blood pressure (BP) control is…

read more

Meta-Analysis of One-Month Dual Antiplatelet Therapy Versus Standard Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention

Feb 19, 2022 by in CARDIOLOGY Comments Off on Meta-Analysis of One-Month Dual Antiplatelet Therapy Versus Standard Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention

The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) is still debated. Current American and European guidelines recommend at least 6 months of DAPT after drug-eluting…

read more

Disparities in Statin Use During Outpatient Visits of Adults (Age 18 to 64 Years) With Coronary Heart Disease in the Medicaid Population in the United States (from the National Ambulatory Medical Care Survey Database 2006 to 2015)

Feb 19, 2022 by in CARDIOLOGY Comments Off on Disparities in Statin Use During Outpatient Visits of Adults (Age 18 to 64 Years) With Coronary Heart Disease in the Medicaid Population in the United States (from the National Ambulatory Medical Care Survey Database 2006 to 2015)

Statins have strong recommendations for secondary prevention of future cardiovascular events in patients with ischemic heart disease (IHD). However, statins remain vastly underused in patients with cardiovascular disease and those…

read more

Potential Safety Signals for Rhabdomyolysis Associated With High-Potency Statin Use With or Without Sacubitril/Valsartan

Feb 19, 2022 by in CARDIOLOGY Comments Off on Potential Safety Signals for Rhabdomyolysis Associated With High-Potency Statin Use With or Without Sacubitril/Valsartan

Regarding the drug interactions between sacubitril/valsartan and statins, we identified 3 reports of rhabdomyolysis with high-potency statins. However, it remains unknown whether the combined use of these medications could lead…

read more

Fractional Flow Reserve in End-Stage Liver Disease

Feb 19, 2022 by in CARDIOLOGY Comments Off on Fractional Flow Reserve in End-Stage Liver Disease

Fractional flow reserve (FFR) determines the functional significance of epicardial stenoses assuming negligible venous pressure (P v ) and microvascular resistance. However, these assumptions may be invalid in end-stage liver…

read more

Hospital Outcomes Among Infants With Interrupted Aortic Arch With Simple and Complex Associated Heart Defects

Feb 19, 2022 by in CARDIOLOGY Comments Off on Hospital Outcomes Among Infants With Interrupted Aortic Arch With Simple and Complex Associated Heart Defects

There is a lack of current, multi-institutional data regarding hospital outcomes of infants with interrupted aortic arch (IAA). We analyzed the Pediatric Health Information System database to identify infants with…

read more
Get Clinical Tree app for offline access